Literature DB >> 6607739

Immunological profiles in alopecia areata.

G M Galbraith, B H Thiers, D B Vasily, H H Fudenberg.   

Abstract

Cell-mediated immunity and auto-immune phenomena were investigated in sixty patients with active alopecia areata of various degrees of severity. Serum auto-antibodies to thyroid antigens were detected in twenty-three patients. Examination of T-lymphocyte populations, lymphocyte DNA synthesis, and lymphokine production in response to mitogen stimulation revealed no differences between the sixty patients and matched healthy control subjects. However, patients with thyroid auto-immunity and/or the presence of alopecia totalis or universalis showed significant reductions in interactive T lymphocytes (recognized by rosette formation with human B lymphoblastoid cells) and diminished production of leukocyte migration inhibition factor in response to stimulation with phytohaemagglutinin. This suggests that immune mechanisms may be involved in the pathogenesis of alopecia areata which is associated with thyroid auto-immunity or which progresses to total hair loss.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607739     DOI: 10.1111/j.1365-2133.1984.tb07462.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Km1 allotype association with one subgroup of alopecia areata.

Authors:  G M Galbraith; J P Pandey
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

2.  Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.

Authors:  R Happle; H M Klein; E Macher
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata.

Authors:  G M Galbraith; J P Pandey
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

Review 4.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.